de Boer, S. E., Sanders, J. S., Bemelman, F. J., Betjes, M. G., Burgerhof, J. G., Hilbrands, L., . . . Berger, S. P. (2021). Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients. BMC Nephrol.
Citación estilo Chicagode Boer, S. E., et al. "Rationale and Design of the OPTIMIZE Trial: OPen Label Multicenter Randomized Trial Comparing Standard IMmunosuppression With Tacrolimus and Mycophenolate Mofetil With a Low Exposure Tacrolimus Regimen In Combination With Everolimus in De Novo Renal Transplantation in Elderly Patients." BMC Nephrol 2021.
Cita MLAde Boer, S. E., et al. "Rationale and Design of the OPTIMIZE Trial: OPen Label Multicenter Randomized Trial Comparing Standard IMmunosuppression With Tacrolimus and Mycophenolate Mofetil With a Low Exposure Tacrolimus Regimen In Combination With Everolimus in De Novo Renal Transplantation in Elderly Patients." BMC Nephrol 2021.